Study to Evaluate the Safety of ATR-04

Clinical trial NCT04731259 · WITHDRAWN

Trial details

NCT number: NCT04731259
Sponsor: Azitra Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epidermal Growth Factor Papulopustular Rosacea

Start date: 2024-01-01
Primary completion: 2026-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.